Boston Scientific Corporation ... and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing ...
In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...
The guidelines recommend that in patients carrying either a pacemaker or an ICD the device ... to the manufacturer of the magnet). Boston Scientific CRM recommends using a programmer to ...
Boston Scientific has shown high revenue and EPS growth rates in recent years. See why I recommend a hold rating for BSX stock.
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks... TEM announces the acquisition of Deep 6 AI, enhancing its AI-driven clinical ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Additionally, eight scientific advancements make it into the ... by surgeon Joseph Murray in Boston, is thus the most important event according to respondents. This kidney transplant between ...
The Smart Medical Implants Market was valued at US$ 5.7 Bn in 2022 and is projected to grow at a CAGR of 18.1% from 2023 to 2031, reaching more than US$ 24.8 Bn by the end of 2031. The increasing ...
Background: Prior studies of cardiac rhythm management devices (pacemakers [PM] and implantable cardioverter defibrillators [ICD]) utilization in the United States have been limited to the ...
© 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...
After hours: March 14 at 7:54:01 PM EDT Loading Chart for BSX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results